These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2587522)

  • 21. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
    Selvin E; Marinopoulos S; Berkenblit G; Rami T; Brancati FL; Powe NR; Golden SH
    Ann Intern Med; 2004 Sep; 141(6):421-31. PubMed ID: 15381515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of correlation of glycosylated haemoglobin level with the duration of diabetes or diabetic angiopathy.
    Blickle JF; North ML; Brogard JM; Reville P
    Ann Med Interne (Paris); 1986; 137(3):264-6. PubMed ID: 3767198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients.
    Asakawa H; Tokunaga K; Kawakami F
    J Diabetes Complications; 2001; 15(2):57-62. PubMed ID: 11274900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylated hemoglobin in a population-based study of diabetes.
    Klein R; Klein BE; Moss SE; Shrago ES; Spennetta TL
    Am J Epidemiol; 1987 Sep; 126(3):415-28. PubMed ID: 3303917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of HbA1c in management of diabetes mellitus.
    Al-Ghamdi AA
    Saudi Med J; 2004 Mar; 25(3):342-5. PubMed ID: 15048173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
    Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
    Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal hemorheology in diabetes mellitus.
    Barnes A; Locke P; Dormandy J; Dormandy T
    Bibl Anat; 1977; (16 Pt 2):428-9. PubMed ID: 603576
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary Function and Retrobulbar Hemodynamics in Subjects With Type 2 Diabetes Mellitus.
    Tai H; Wang MY; Zhao YP; Li LB; Jiang XL; Dong Z; Lv XN; Liu J; Dong QY; Liu XG; Kuang JS
    Respir Care; 2017 May; 62(5):602-614. PubMed ID: 28246307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM.
    Pfeiffer A; Middelberg-Bisping K; Drewes C; Schatz H
    Diabetes Care; 1996 Oct; 19(10):1113-7. PubMed ID: 8886558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
    Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
    Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphofunctional changes in the erythrocytes in diabetes mellitus].
    Efimov AS; Pleshanov EV; Gogina IF
    Probl Endokrinol (Mosk); 1988; 34(2):13-5. PubMed ID: 3393498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microvascular complications in pancreatic diabetes].
    Gasiorowska A; Czupryniak L; Małecka-Panas E; Wiśniewska-Jarosińska M; Drzewoski J
    Pol Arch Med Wewn; 2001 Jun; 105(6):469-74. PubMed ID: 11865577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus.
    Hamada Y; Kitoh R; Raskin P
    Diabet Med; 1993; 10(1):33-8. PubMed ID: 8435985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus.
    Shin S; Ku YH; Ho JX; Kim YK; Suh JS; Singh M
    Clin Hemorheol Microcirc; 2007; 36(3):253-61. PubMed ID: 17361027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of erythrocyte sorbitol-blood glucose ratios in type II diabetes mellitus.
    Aida K; Tawata M; Shindo H; Onaya T
    Diabetes Care; 1990 May; 13(5):461-7. PubMed ID: 2351023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
    Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Disordered cerebral hemodynamics in diabetic patients (based on myelographic data)].
    Cherniĭ VI; Mikhaĭlichenko TE; Bessmertnaia EV; Koval' EN
    Lik Sprava; 1999 Mar; (2):59-63. PubMed ID: 10424044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
    Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.